Shree Ganesh Bio-Tech (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Shree Ganesh Bio-Tech (India) Ltd. on BSE

Load latest

Shree Ganesh Bio-Tech (India) Ltd.

30 Mar 2021

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Closure of Trading Window

BSE India

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and clarification given by NSE vide letter no. NSE/CML/2019/11 dated 2nd April 2019 and BSE vide circular no. LIST/COMP/01/2019-20 dated 2nd April 2019 regarding trading restriction period and Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed from Thursday 1st April, 2021 till 48 hours after announcement / declaration of Audited Financial Results of the company for the quarter and financial year ended as on 31st March, 2021. The date of Board Meeting will be informed in due course.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

30 Mar 2021

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Closure of Trading Window

BSE India

pdf

Shree Ganesh Bio-Tech (India) Ltd.

19 Jan 2021

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation …

BSE India

Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 31st December 2020, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular. This is for your information and records.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

19 Jan 2021

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Unaudited Financial Result For Quarter Ending 31St December …

BSE India

In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith unaudited financial result for quarter ended 31st December 2020. . Kindly take the same on your record and oblige. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

19 Jan 2021

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Unaudited Financial Result For Quarter Ending 31St December …

BSE India

pdf

Shree Ganesh Bio-Tech (India) Ltd.

11 Jan 2021

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 …

BSE India

Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/01/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 19th January 2021 inter alia, to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2020. Please take the above intimation in your records. Thanking You,

pdf

Shree Ganesh Bio-Tech (India) Ltd.

07 Jan 2021

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Shareholding for the Period Ended December 31, 2020

BSE India

Shree Ganesh Biotech (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here

Shree Ganesh Bio-Tech (India) Ltd.

05 Jan 2021

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from Satellite Corporate Services Private Limited, Registrar & Share Transfer Agent of the Company for the quarter ended 31st December, 2020. This is for your information and records.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

01 Jan 2021

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Statement Of Investor Complaints For The Quarter Ended December 2020

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- AMAN PRAVINKUMAR PATELDesignation :- Managing Director / Whole Time Director

Shree Ganesh Bio-Tech (India) Ltd.

29 Dec 2020, 11:50AM

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Closure of Trading Window

BSE India

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and clarification given by NSE vide letter no. NSE/CML/2019/11 dated 2nd April 2019 and BSE vide circular no. LIST/COMP/01/2019-20 regarding trading restriction period and Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed from Friday, 1st January 2021 till 48 hours after announcement / declaration of Unaudited Financial Results for the quarter ended on 31st December 2020. The date of Board Meeting will be informed in due course. Thanking You.

pdf

Is Shree Ganesh Bio-Tech (India) Ltd. worth buying?

272 Votes:

Buy 73.53%

Sell 8.82%

Hold 17.65%